000 01421 a2200385 4500
005 20250516062548.0
264 0 _c20111220
008 201112s 0 0 eng d
022 _a1536-3678
024 7 _a10.1097/MPH.0b013e31822aa4ec
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLn, Ramya
245 0 0 _aIn silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.
_h[electronic resource]
260 _bJournal of pediatric hematology/oncology
_cDec 2011
300 _a617-21 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAsparaginase
_xchemistry
650 0 4 _aAsparagine
_xchemistry
650 0 4 _aCatalytic Domain
650 0 4 _aChild
650 0 4 _aComputer Simulation
650 0 4 _aDrug Design
650 0 4 _aGlutaminase
_xchemistry
650 0 4 _aGlutamine
_xchemistry
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aMutagenesis, Site-Directed
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aProtein Engineering
_xmethods
700 1 _aDoble, Mukesh
700 1 _aRekha, V P B
700 1 _aPulicherla, K K
773 0 _tJournal of pediatric hematology/oncology
_gvol. 33
_gno. 8
_gp. 617-21
856 4 0 _uhttps://doi.org/10.1097/MPH.0b013e31822aa4ec
_zAvailable from publisher's website
999 _c21272853
_d21272853